Skip to content
Menu
Home
about AesMed
AesMed Story
AGF39
AesMed Expands Global Reach with Exclusive Distribution Agreement in Azerbaijan
2025-09-06
At AesMed, our mission has always been clear: to bring innovative and effective ...
Read More
Latest Posts
SGF57: The Original Blueprint Behind AGF39 – Series Part 1
AGF39: Clinical Experience, Real-World Data, and Global Adoption- part 4
CytoMesopecia – Cytokines Mesotherapy for Alopecia- part 3
Why Korea Leads Cytokines Mesotherapy for Hair Regrowth- part 2
The Rise of Cytokines in Hair Regrowth: From Biology to Clinical Practice -Part 1
AesMed at FUE ASIA SAARC Regional Workshop 2026:
A New Beginning: AesMed Steps Forward Into 2026 With Purpose and Determination
CytoMesopecia – Cytokines Mesotherapy for Alopecia (Part 2)
CytoMesopecia – Cytokines Mesotherapy for Alopecia (Part 1)
AesMed Expands Its Mission Through an Official MOU With the Korean Alopecia Areata Patients Association
Search for:
